Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Director Shareholding - AMENDMENT

20 Jul 2016 16:59

RNS Number : 7875E
First Derivatives PLC
20 July 2016
 

20 July 2016

 

Amendment of RNS 6526E published at 17:03 on 19 July 2016 - The only amendment made to the below announcement is to change the date of admission of the new Ordinary Shares to trading on AIM and ESM from 22 July 2016 to 25 July 2016

 

First Derivatives plc

("FD" or the "Company")

 

Director dealing and issue of equity

 

 

FD (AIM: FDP.L, ESM: FDP.I) announces that on 18 July 2016 certain employees and a Director exercised options over a total of 217,000 ordinary shares of 0.5p each in the Company ("Ordinary Shares"). Of this total exercise, Graham Ferguson, Chief Financial Officer, exercised 150,000 share options and on the same day sold 170,000 Ordinary Shares at a price of 1,725p per share. On 19 July Mr Ferguson sold a further 30,000 Ordinary Shares at a price of 1,725p. Following these transactions Mr Ferguson holds a total of 122,647 Ordinary Shares representing 0.5% of the total issued share capital of the Company.

 

Furthermore, on 19 July 2016 Mr Ferguson was awarded 200,000 share options over Ordinary Shares. These options have an exercise price of 1,717p per share and will vest on the third anniversary of the date of the award, subject to meeting demanding performance criteria related to the achievement of total shareholder returns during this period. Following this award, Mr Ferguson holds share options over a total of 200,000 Ordinary Shares.

 

As a result of the above exercise of options, application has been made for 217,000 new Ordinary Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 25 July 2016. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares. Following this allotment, the total issued share capital of the Company will increase to 24,531,639 Ordinary Shares.

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,600 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHRMMATMBATBLF
Date   Source Headline
2nd Feb 20229:33 amRNSHolding(s) in Company
20th Jan 20227:00 amRNSDirectorate Change
17th Jan 20227:00 amRNSDirector/PDMR Shareholding
31st Dec 202110:10 amRNSTotal Voting Rights
13th Dec 20212:59 pmRNSIssue of Equity
9th Dec 20219:40 amRNSDirector/PDMR Shareholding
1st Dec 20211:55 pmRNSHolding(s) in Company
30th Nov 202110:52 amRNSTotal Voting Rights
18th Nov 20217:00 amRNSAppointment of Adviser
15th Nov 20215:12 pmRNSIssue of Equity
9th Nov 20218:48 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSResults for the six months ended 31 August 2021
11th Oct 20217:00 amRNSHolding(s) in Company
6th Oct 20214:27 pmRNSHolding(s) in Company
6th Oct 20217:00 amRNSNotice of Results
1st Sep 20219:29 amRNSTotal Voting Rights
25th Aug 20215:37 pmRNSIssue of Equity
11th Aug 20217:00 amRNSLTIP Award
30th Jul 20217:00 amRNSDirectorate Change
8th Jul 20215:23 pmRNSResult of AGM
2nd Jul 202111:47 amRNSHolding(s) in Company
30th Jun 202112:16 pmRNSTotal Voting Rights
22nd Jun 20215:44 pmRNSIssue of Equity
15th Jun 20211:20 pmRNSHolding(s) in Company
14th Jun 20215:05 pmRNSHolding(s) in Company
8th Jun 20215:19 pmRNSNotice of AGM & Change of Name
1st Jun 202110:31 amRNSTotal Voting Rights
26th May 20214:06 pmRNSHolding(s) in Company
25th May 20216:08 pmRNSIssue of Equity
18th May 20217:00 amRNSFull Year Results
13th Apr 20217:00 amRNSTrading Update
31st Mar 202110:29 amRNSTotal Voting Rights
3rd Mar 20216:13 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAppointment of Eric Raab as KX CTO
1st Mar 20217:00 amRNSAppointment of Scott Matthews as CEO for MRP
26th Feb 20214:18 pmRNSIssue of Equity
26th Feb 20219:25 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPartial sale of Quantile Technologies holding
15th Feb 20214:28 pmRNSIssue of Equity
29th Jan 20219:59 amRNSTotal Voting Rights
25th Jan 20216:18 pmRNSIssue of Equity
31st Dec 202011:17 amRNSTotal Voting Rights
9th Dec 20207:00 amRNSDirectorate Change
8th Dec 202012:46 pmRNSIssue of Equity
30th Nov 20209:35 amRNSTotal Voting Rights
16th Nov 20203:21 pmRNSHolding(s) in Company
13th Nov 20204:08 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSResult of secondary placing
30th Oct 20201:30 pmRNSIssue of Equity
27th Oct 20207:00 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.